Nexien BioPharma Inc (NXEN)

[GOIN/Green]

With the delay to crosslist to CSE we are at least a year away. They just announced yesterday their API scientist. That is basically the person responsible for the raw materials to build and qualify the formulation process. They can't start clinical trials until they have the formulation process constructed and qualified. Being that this is a start up I would say we are looking at a good year before clinical trial of actual medication are announced and in order to get there they will need to raise capital as their burn rate is to much. We are now trading below what the private placement holders purchased at so I would expect to hear some push to get the share price back up